Accuray PE Ratio 2010-2024 | ARAY
Current and historical p/e ratio for Accuray (ARAY) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Accuray PE ratio as of May 10, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Accuray PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-10 | 1.62 | 0.00 | |
| 2024-03-31 | 2.47 | $-0.16 | 0.00 |
| 2023-12-31 | 2.83 | $-0.15 | 0.00 |
| 2023-09-30 | 2.72 | $-0.07 | 0.00 |
| 2023-06-30 | 3.87 | $-0.10 | 0.00 |
| 2023-03-31 | 2.97 | $-0.11 | 0.00 |
| 2022-12-31 | 2.09 | $-0.13 | 0.00 |
| 2022-09-30 | 2.08 | $-0.11 | 0.00 |
| 2022-06-30 | 1.96 | $-0.06 | 0.00 |
| 2022-03-31 | 3.31 | $-0.14 | 0.00 |
| 2021-12-31 | 4.77 | $-0.13 | 0.00 |
| 2021-09-30 | 3.95 | $-0.08 | 0.00 |
| 2021-06-30 | 4.52 | $-0.07 | 0.00 |
| 2021-03-31 | 4.95 | $0.04 | 123.75 |
| 2020-12-31 | 4.17 | $0.07 | 59.57 |
| 2020-09-30 | 2.40 | $0.14 | 17.14 |
| 2020-06-30 | 2.03 | $0.03 | 67.67 |
| 2020-03-31 | 1.90 | $0.02 | 95.00 |
| 2019-12-31 | 2.82 | $-0.02 | 0.00 |
| 2019-09-30 | 2.77 | $-0.19 | 0.00 |
| 2019-06-30 | 3.87 | $-0.09 | 0.00 |
| 2019-03-31 | 4.77 | $-0.17 | 0.00 |
| 2018-12-31 | 3.41 | $-0.22 | 0.00 |
| 2018-06-30 | 4.10 | $-0.28 | 0.00 |
| 2018-03-31 | 5.00 | $-0.33 | 0.00 |
| 2017-12-31 | 4.30 | $-0.34 | 0.00 |
| 2017-09-30 | 4.00 | $-0.34 | 0.00 |
| 2017-06-30 | 4.75 | $-0.34 | 0.00 |
| 2018-09-30 | 4.50 | $-0.40 | 0.00 |
| 2017-03-31 | 4.75 | $-0.38 | 0.00 |
| 2016-12-31 | 4.60 | $-0.31 | 0.00 |
| 2016-09-30 | 6.37 | $-0.28 | 0.00 |
| 2016-06-30 | 5.19 | $-0.28 | 0.00 |
| 2016-03-31 | 5.78 | $-0.26 | 0.00 |
| 2015-12-31 | 6.75 | $-0.31 | 0.00 |
| 2015-09-30 | 5.00 | $-0.36 | 0.00 |
| 2015-06-30 | 6.74 | $-0.52 | 0.00 |
| 2015-03-31 | 9.30 | $-0.58 | 0.00 |
| 2014-12-31 | 7.55 | $-0.60 | 0.00 |
| 2014-09-30 | 7.26 | $-0.54 | 0.00 |
| 2014-06-30 | 8.80 | $-0.47 | 0.00 |
| 2014-03-31 | 9.60 | $-0.59 | 0.00 |
| 2013-12-31 | 8.70 | $-0.95 | 0.00 |
| 2013-09-30 | 7.38 | $-1.28 | 0.00 |
| 2013-06-30 | 5.74 | $-1.41 | 0.00 |
| 2013-03-31 | 4.64 | $-1.44 | 0.00 |
| 2012-12-31 | 6.43 | $-1.23 | 0.00 |
| 2012-09-30 | 7.08 | $-0.98 | 0.00 |
| 2012-06-30 | 6.82 | $-1.02 | 0.00 |
| 2012-03-31 | 7.06 | $-1.14 | 0.00 |
| 2011-12-31 | 4.23 | $-0.95 | 0.00 |
| 2011-09-30 | 4.01 | $-0.73 | 0.00 |
| 2011-06-30 | 8.01 | $-0.43 | 0.00 |
| 2011-03-31 | 9.02 | $0.05 | 180.40 |
| 2010-12-31 | 6.75 | $0.11 | 61.36 |
| 2010-09-30 | 6.22 | $0.02 | 311.00 |
| 2010-06-30 | 6.63 | $0.04 | 165.75 |
| 2010-03-31 | 6.07 | $-0.02 | 0.00 |
| 2009-12-31 | 5.61 | $-0.04 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.161B | $0.448B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.369B | 27.43 |
| Intuitive Surgical (ISRG) | United States | $137.163B | 82.63 |
| Edwards Lifesciences (EW) | United States | $52.257B | 34.01 |
| DexCom (DXCM) | United States | $50.526B | 76.54 |
| IQVIA Holdings (IQV) | United States | $42.649B | 24.74 |
| IDEXX Laboratories (IDXX) | United States | $42.105B | 49.35 |
| Alcon (ALC) | Switzerland | $40.439B | 29.82 |
| STERIS (STE) | Ireland | $22.859B | 26.71 |
| Waters (WAT) | United States | $20.828B | 30.61 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.805B | 0.00 |
| Hologic (HOLX) | United States | $17.536B | 19.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.746B | 14.88 |
| ShockWave Medical (SWAV) | United States | $12.410B | 77.23 |
| Sysmex ADR (SSMXY) | Japan | $10.536B | 33.04 |
| Teleflex (TFX) | United States | $9.606B | 14.95 |
| Globus Medical (GMED) | United States | $8.761B | 25.68 |
| Penumbra (PEN) | United States | $8.229B | 93.52 |
| Masimo (MASI) | United States | $6.464B | 37.24 |
| Glaukos (GKOS) | United States | $5.564B | 0.00 |
| TransMedics (TMDX) | United States | $4.281B | 406.19 |
| Integer Holdings (ITGR) | United States | $3.818B | 23.07 |
| LivaNova (LIVN) | United Kingdom | $3.363B | 19.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.222B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.865B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.825B | 19.38 |
| Inari Medical (NARI) | United States | $2.544B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.453B | 20.75 |
| RxSight (RXST) | United States | $2.194B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.048B | 8.93 |
| Veracyte (VCYT) | United States | $1.634B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.611B | 0.00 |
| Artivion (AORT) | United States | $0.982B | 94.12 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.899B | 17.48 |
| OPKO Health (OPK) | United States | $0.892B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.830B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.741B | 0.00 |
| Paragon 28 (FNA) | United States | $0.643B | 0.00 |
| SiBone (SIBN) | United States | $0.632B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.626B | 21.25 |
| IRadimed (IRMD) | United States | $0.552B | 30.91 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.482B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.411B | 0.00 |
| Nevro (NVRO) | United States | $0.360B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.330B | 11.30 |
| Treace Medical Concepts (TMCI) | United States | $0.272B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.267B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.251B | 0.00 |
| NeuroPace (NPCE) | United States | $0.245B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.242B | 0.00 |
| Inogen (INGN) | United States | $0.199B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.180B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.162B | 8.22 |
| ClearPoint Neuro (CLPT) | United States | $0.161B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.159B | 0.00 |
| CVRx (CVRX) | United States | $0.157B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.102B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 18.24 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Envoy Medical (COCH) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.060B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| InspireMD (NSPR) | Israel | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| LENSAR (LNSR) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.020B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |